00-f5 Title and Logo 00-f6
 guide 目录
 siteinfo 公告


参考文献

 第01章
 第02章
 第03章
 第04章
 第05章
 第06章
 第07章
 第08章
 第09章
 第10章
 第11章
 第12章
 第13章
 第14章
 第15章
 第16章
 第17章
 第18章
 第19章
 第20章
 第21章


 

>参考文献

第05章

Brady TJ, Wismer GL, Buxton R, Stark DD, Rosen BR. Magnetic resonance chemical shift imaging. Magn Reson Ann 1986; 55-79.

Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hänicke W, Sauter R. Localized high resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in-vivo. Magn Reson Med 1988; 9: 79-93.

Gadian DG. Proton NMR studies of brain metabolism. Phil Trans R Soc Lond A 1990; 333: 561-570.

Hugg JW, Matson GB, Twieg DB, Maudsley AA, Sappey-Marinier D, Weiner MW. Phosphorus-31 MR spectroscopic imaging (MRSI) of normal and pathological human brains. Magn Reson Imag 1992; 10: 227-243.

Kimmich R, Hoepfel D. Volume selective multipulse spin-echo spectroscopy. J Magn Reson 1987; 72: 379-387.

Kohler SJ, Perry SB, Stewart LC, Atkinson DE, Clarke K, Ingwall JS. Analysis of 23Na NMR spectra from isolated perfused hearts. Magn Reson Med 1991; 18: 15-27.

Matson GB, Weiner MW. Chapter 15: Spectroscopy. In: Stark DD, Bradley WG (eds.). Magnetic resonance imaging. 3rd edition. Vol. 1. St. Louis (USA): Mosby Year Book Inc 1999. 181-214.

Miller BL. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 1991; 4: 47-52.

Öz G, Alger JR, Barker PB, et mult al. Clinical proton MR spectroscopy in central nervous system disorders. Radiology 2014; 270: 658-679.

Ordidge RJ, Connelly A, Lohman JAB. Image selected in vivo spectroscopy (ISIS). A new technique for spatially selective NMR spectroscopy. J Magn Reson 1986; 66: 283-294.

Pouremad R, Wyrwicz AM. Cerebral metabolism of fluoro-desoxyglucose measured with 19F NMR spectroscopy. NMR Biomed 1991; 4: 161-166.

Rashid SA, Adam WR, Craik DJ, Shehan BP, Wellard RM. Factors affecting 39K NMR detectability in rat tissue. Magn Reson Med 1991; 17: 213-224.

Rubaek Danielsen E, Ross B. Magnetic resonance spectroscopy diagnosis of neurological diseases. New York: Marcel Dekker 1999.

Sauter R, Schneider M, Wicklow K, Kolem H. Current status of clinically relevant techniques in magnetic resonance spectroscopy. Electromedica 1992; 60: 32-54.

Shulman GI, Rothman DL, Shulman RG. 13C NMR studies of glucose disposal in normal and non-insulin-dependent diabetic humans. Phil Trans R Soc Lond A 1990; 333: 525-529.

Southon TE, Gribbestad IS, Nilsen G, Nordlid K, Svarliaunet AJ, Unsgaard G, Rinck PA. 31P magnetic resonance spectroscopy in the follow-up of therapy of patients with astrocytomas. Radiol Diagn 1993; 34: 11-18.

Timm G, Rinck PA, Southon TE, Aasly J, Michler RP. 31P nuclear magnetic resonance spectroscopy in patients with fibromyalgia versus normals and patients with different muscular diseases. Quarterly Magn Res in Biol and Med 1996; 3: 89-92.


spaceholder 600 spaceholder 600

LogoTop
LogoBottom
space
00-f1
space
00-f2
space
00-f3
space
00-f4
space
00-f7